Artemis Medicare Services Limited (NSE:ARTEMISMED)
India · Delayed Price · Currency is INR 267.60
-5.76 (-2.11%)
Jun 1, 2026, 3:29 PM IST
Artemis Medicare Services Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,036 | 826.26 | 491.41 | 385.98 | 318.14 |
Depreciation & Amortization | 480.66 | 431.29 | 383.41 | 293.52 | 215.11 |
Other Amortization | - | 20.36 | 19.76 | 16.52 | 6.82 |
Loss (Gain) From Sale of Assets | 0.08 | -21.35 | -2.14 | -11.41 | 5.21 |
Stock-Based Compensation | - | 9.3 | 21.75 | 40.31 | 77.53 |
Provision & Write-off of Bad Debts | 23.5 | 30.48 | 21.3 | 21.48 | 1.46 |
Other Operating Activities | 183.09 | 126.88 | 195.01 | 223.45 | 297.94 |
Change in Accounts Receivable | -207.26 | -96.55 | -37.1 | -218.27 | -195.21 |
Change in Inventory | -34.41 | 1.05 | 39.08 | -15.94 | -27.73 |
Change in Accounts Payable | -13.78 | 70.55 | 74.9 | 290.92 | 35.3 |
Change in Other Net Operating Assets | -148.6 | 57.89 | -118.83 | 245.06 | -139.22 |
Operating Cash Flow | 1,319 | 1,456 | 1,089 | 1,272 | 595.35 |
Operating Cash Flow Growth | -9.39% | 33.77% | -14.40% | 113.59% | 118.39% |
Capital Expenditures | -1,049 | -931.51 | -725.53 | -1,465 | -1,089 |
Sale of Property, Plant & Equipment | 49.21 | 26.43 | 3.24 | 15.4 | 3.61 |
Cash Acquisitions | -1,349 | - | - | - | - |
Investment in Securities | 1,197 | -3,070 | -186.6 | -160.74 | -0.41 |
Other Investing Activities | 287.25 | 124.51 | 38.99 | 27.93 | 13.58 |
Investing Cash Flow | -900.3 | -3,854 | -881.35 | -1,582 | -1,072 |
Long-Term Debt Issued | 642.44 | 3,508 | 453.25 | 828 | 791.36 |
Total Debt Issued | 642.44 | 3,508 | 453.25 | 828 | 791.36 |
Long-Term Debt Repaid | -808.52 | -415.44 | -371.81 | -275.18 | -245.95 |
Total Debt Repaid | -808.52 | -415.44 | -371.81 | -275.18 | -245.95 |
Net Debt Issued (Repaid) | -166.08 | 3,093 | 81.45 | 552.82 | 545.41 |
Issuance of Common Stock | 1.74 | 1.74 | 1.74 | 1.74 | - |
Common Dividends Paid | -61.32 | -59.76 | -61.14 | - | - |
Other Financing Activities | -275.35 | -367.09 | -311.85 | -172.34 | -103.16 |
Financing Cash Flow | -501.01 | 2,667 | -289.79 | 382.22 | 442.25 |
Net Cash Flow | -81.84 | 269.8 | -82.6 | 71.7 | -34.63 |
Free Cash Flow | 270.01 | 524.65 | 363.01 | -193.11 | -493.66 |
Free Cash Flow Growth | -48.54% | 44.53% | - | - | - |
Free Cash Flow Margin | 2.43% | 5.60% | 4.13% | -2.62% | -8.90% |
Free Cash Flow Per Share | 1.71 | 3.37 | 2.61 | -1.39 | -3.55 |
Cash Interest Paid | - | 276.01 | 329.7 | 201.36 | 110.63 |
Cash Income Tax Paid | - | 138.5 | 156 | 28.75 | -167.05 |
Levered Free Cash Flow | 101.15 | 22.53 | -107.19 | -426.5 | -595.23 |
Unlevered Free Cash Flow | 274.2 | 200.7 | 66.31 | -318.69 | -536.74 |
Change in Working Capital | -404.05 | 32.95 | -41.95 | 301.77 | -326.86 |